Science: Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments
“One of the world’s biggest trials of COVID-19 therapies released its long-awaited interim results yesterday — and they’re a letdown. None of the four treatments in the Solidarity trial, which enrolled more than 11,000 patients in 400 hospitals around the globe, increased survival — not even the much-touted antiviral drug remdesivir. Scientists at the World Health Organization (WHO) released the data as a preprint on medRxiv last night ahead of its planned publication in the New England Journal of Medicine…” (Kupferschmidt, 10/16).

Additional coverage of the study’s interim results is available from Financial Times, The Hill, New York Times, Reuters, and The Telegraph.